Forbion — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Milestone Pharmaceuticalsmilestonepharma.com in 𝕏Series C · Jul 2017 · $55M

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

BiotechDigital HealthHealthtechMedical DevicesMontreal, US

Ela Borenstein(Director)Francis Plat(Executive Officer)Yves Rosconi(Director)Scott Weiner(Director)Martin Maguire(Executive Officer)Philippe Douville(Executive Officer, Director)

Board seatMarco Boorsma· per SEC Form D

Co-investorsPappas Capital Amplitude Venture Capital Domain Associates RTW Investments L.P.

Nerre Therapeuticsnerretherapeutics.comSeries B · Jan 2017 · $29M

Co-investorsAdvent Life Sciences Fountain Healthcare Partners OrbiMed Columbus Venture Partners Redwood Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.